AJR:196, May 2011
Chirag N. Patel, Sarfraz A. Nazir, Zubair Khan, Fergus V. Gleeson, Kevin M. Bradley
OBJECTIVE. This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence.
CONCLUSION. There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma—in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.